Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 9.89 M9.96 M10.04 M9.5 M13.65 M17.61 M 50.79 M Research & development —————— — Operating income 42.19 M36.28 M50.69 M56.44 M62.6 M63.39 M 233.11 M Non-Operating Income, Total -2.97 M-5.55 M1.1 M1.55 M1.12 M1.27 M 5.05 M Interest expense, net of interest capitalized 23.68 M23.52 M22.14 M20.5 M21.46 M22.86 M 86.95 M Non-Operating Income, excl. Interest Expenses -26.64 M-29.07 M-21.03 M-18.95 M-20.34 M-21.59 M -81.91 M Unusual income/expense —————— — Pretax income 16.16 M14.46 M22.31 M25.68 M22.4 M20.72 M 91.11 M Equity in earnings —————— — Taxes 2.25 M2.24 M3.14 M3.44 M3.45 M3.18 M 13.21 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 13.91 M12.21 M19.17 M22.24 M18.95 M17.55 M 77.9 M Discontinued operations —————— — Net income 13.91 M12.21 M19.17 M22.24 M18.95 M17.55 M 77.9 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 13.91 M12.21 M19.17 M22.24 M18.95 M17.55 M 77.9 M Basic earnings per share (Basic EPS) 0.410.360.560.660.490.42 2.13 Diluted earnings per share (Diluted EPS) 0.40.360.550.650.480.42 2.1 Average basic shares outstanding 34.01 M34.03 M33.95 M34 M38.68 M41.08 M — Diluted shares outstanding 34.51 M34.45 M34.41 M34.46 M39.1 M41.54 M — EBITDA 26.59 M13.07 M28.84 M37.11 M43.2 M43.49 M 152.63 M EBIT 18.51 M12.77 M28.55 M35.94 M41.14 M40.53 M 146.16 M Cost of revenue 1.27 M2.16 M3.01 M433 K644 K880 K 4.97 M Other cost of goods sold 1.22 M1.21 M1.24 M1.25 M1.67 M1.8 M 5.96 M Depreciation & amortization (cash flow) 303 K302 K284 K1.17 M2.06 M2.96 M 6.47 M